Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 2.15
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Vivanza Biosciences Ltd. engages in the manufacture and trade of pharmaceutical products. Its product includes Intravenous (IV) Fusion. The company was founded on March 03, 1982 and is headquartered in Ahmedabad, India.
Company Valuation
From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks.
Data is available to registered users only
Buy
Sell